Cancer Vaccine
Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program
Moderna
PR-M11-20-009Nov 11, 2020
COVID-19 Vaccine Funding
Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for COVID-19 Vaccine
Moderna
PR-M07-20-NI-40Jul 27, 2020
COVID-19 Vaccine
Moderna Begins Phase 3 COVE Study of mRNA Vaccine Against COVID-19
Moderna
PR-M07-20-NI-39Jul 27, 2020
COVID-19 Vaccine
Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19
Moderna
PR-M06-20-NI-016Jun 12, 2020
COVID-19 Vaccine
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Nice Insight
PR-M05-20-NI-027May 18, 2020
Vaccine Collaboration
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus
Moderna
PR-M05-20-NI-001May 01, 2020
Moderna Highlights Opportunity of mRNA Vaccines
Moderna
PR-M04-20-NI-019Apr 14, 2020
Coronavirus
Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Vaccine Against Novel Coronavirus
Moderna
PR-M03-20-NI-025Mar 17, 2020
Positive Results
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)
Moderna
PR-M09-19-NI-039Sep 16, 2019
Vaccines
Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains
Moderna
PR-M05-19-NI-041May 14, 2019
Award
DPS Group and TRIA Congratulate Moderna on ISPE 2019 Facility of the Future Category Award
Arcadis
PR-M04-19-NI-029Apr 09, 2019
Product Pipeline
Moderna Announces 19 Development Candidates at JPM
Guy Tiene
Nice Insight
PAO-M01-18-NI-021Jan 12, 2018